|Publication number||US4634443 A|
|Application number||US 06/752,137|
|Publication date||6 Jan 1987|
|Filing date||5 Jul 1985|
|Priority date||5 Jul 1985|
|Also published as||CA1253651A1, EP0207426A2, EP0207426A3|
|Publication number||06752137, 752137, US 4634443 A, US 4634443A, US-A-4634443, US4634443 A, US4634443A|
|Inventors||Terry M. Haber|
|Original Assignee||Habley Medical Technology Corporation|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (8), Referenced by (64), Classifications (9), Legal Events (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
1. Field of the Invention
This invention relates to a gastrointestinal sphincter for surgical implantation to surround and embrace a patient's lumen (e.g. bowel) for articulating the lumen by means of a single, continuous fluid circuit by which variable occlusive pressures can be selectively and controllably generated for achieving coaptive continence.
2. Prior Art
Cancer of the colon typically occurs in the rectosigmoidal area of a patient. Halting the spread of such cancer frequently requires a colostomy during which the sphincter ani muscle is surgically excised. While the patient's bowel remains intact, there is no longer an associated sphincter muscle to hold the patient continent and control the movement of fecal material through the bowel. In such a case, the surgeon usually extends the patient's colon to a location outside the stomach. A mouth portion or stoma is formed at the external colon end and a bag is attached thereto to receive fecal material.
The corresponding arrangement of tubes and external valves which are needed to form the stoma end of the colon are often irritating to the patient. Moreover, externally worn bags are generally cumbersome in that they are subject to either changing or replacement, thereby increasing costs and/or subjecting the patient to a possible unsanitary environment. What is more, external belts, adhesives, and the like are typically required to secure the external bag to the body of the patient. Therefore, not only is the patient's mobility limited but the externally worn bag has been known to become separated from the patient. Moreover, the wearer of such externally worn bags sometimes requires assistance in attaching or removing the bag.
The best psychological and physiological treatment of a colostomy patient is to repair and artificially replace internal tissue so that the anal orifice terminates at its presurgery location. However, the artificial sphincter mechanisms heretofore available are not ideally suitable to reliably accomplish the foregoing.
Examples of conventional sphincteric mechanisms can be found be referring to one or more of the following U.S. patents: Nos.
3,863,622 Feb. 4, 1975
4,222,377 Sept. 16, 1980
4,386,601 June 7, 1983
4,417,567 Nov. 29, 1983
4,419,985 Dec. 13, 1983
Briefly, and in general terms, an elastofluidic, gastrointestinal sphincter is disclosed for surgical implantation around a patient's lumen, such as the bowel. The sphincter includes a continence producing occlusion cuff which is positioned around the bowel to achieve coaptation for the treatment of incontinence. The occlusion cuff includes a hollow, expansible patient actuated chamber arranged to embrace the bowel and generate diametric occlusive pressures for reliably occluding the bowel with a precise and minimal pressure. Communicating with the hollow chamber in a single continuous fluid circuit are first and second fluid paths. Each fluid path includes a fluid filled reservoir and a flow control check valve. The reservoirs are implanted at a manually accessible location of the body to permit the patient to locate and actuate one or both reservoirs and thereby cause fluid to be delivered via respective fluid paths to the expansible chamber to cause a corresponding inflation thereof. Since each of the reservoirs may be selectively actuated to deliver a fluid supply to inflate the expansible chamber, the occlusion cuff is adapted to produce variable occlusive pressure levels for achieving coaptive continence. A fluid filled physician control port communicates with one of the first or second fluid paths. The port is implated so as to be accessible to a fluid filled syringe. In the event that the occlusive pressures generated by means of the patient actuated fluid reservoirs are insufficient to achieve coaptation, the physician may continuously and accurately increase the application of occlusive pressure to the bowel by inserting a syringe into the physician control port so as to supply additional fluid to further inflate the occlusion cuff chamber. Thus, by virtue of the present invention, the physician may selectively adjust the total occlusive forces being generated for achieving coaptive continence without subjecting the patient to additional surgery, so that the sphincter can be individually customized to generate the minimal occlusive pressures required by the patient to achieve coaptation.
The continence producing cuff also includes a super-expansive membrane formed therein having a spring-like memory and being adapted to accommodate a distension of the bowel, such as that which may be caused by a fecal impaction. The extensible membrane has one or more apertures formed therein, the size and number of which apertures establishing a minimum threshold pressure at which the membrane first begins to stretch in response to a distension of the bowel.
FIG. 1 is a front elevation of the gastrointestinal sphincter and the single, continuous fluidic circuit thereof which form the present invention;
FIG. 2 shows the present sphincter surrounding a patient's bowel;
FIG. 3 shows the sphincter of FIG. 2 and a super-expansive area thereof for accommodating a distension in the patient's bowel, such as that caused by fecal impaction;
FIG. 4 shows the details of the continence producing occlusion cuff which forms the sphincter of FIG. 1;
FIG. 5 is a cross section of the physician control port which is located in the fluid circuit of FIG. 1;
FIGS. 6 and 7 are cross sections of a fluid reservoir in expanded and compressed conditions, respectively, which reservoir is located in the fluid circuit of FIG. 1; and
FIGS. 8-10 illustrate an automatic, self centering feature of the present sphincter for optimally positioning the patient's bowel so that coaptive continence may be achieved by means of diametric compression.
The elastofluidic, gastrointestinal sphincter which forms the present invention and the single, continuous fluidic circuit thereof which permits the sphincter to be tailored to the tissue requirements of the patient are best described while referring initially to FIG. 1 of the drawings. The sphincter includes a generally flat, continence producing occlusion cuff 1 having a body formed from a low durometer, biocompatible, capsule initiating elastomeric material, such as silicone, polyurethane, or the like. In the particular embodiment to be described, the occlusion cuff 1 is adapted to embrace and occlude a lumen, such as, for example, the bowel of a patient who has undergone a colostomy and whose sphincter ani muscle has been removed by surgery to remedy a cancer of the colon. However, it is also to be understood that the present sphincter is also applicable to any other suitable lumen, such as the urethra, the esophagus, a vein, an artery or the vas deferins.
Since the details of continence producing occlusion cuff 1 will be explained when referring to FIG. 4, only a brief description of occlusion cuff 1 is provided hereat. Occlusion cuff 1 includes an exterior layer 48 which is fabricated with a silicone impregnated reinforcing surgical mesh. A non-reinforced interior layer 49 of cuff 1 surrounds a continuous, hollow, expansible chamber 2 which is adapted to be filled with a fluid such that occlusive pressures can be occasionally and variably generated to achieve minimum pressure coaptive continence. A fluid by which to fill the chamber 2 of occlusion cuff 1 may be a low viscosity, isotonic, radio-opaque fluid. During sphincter manufacture, chamber 2 is initially filled with a minimal volume of fluid so as to displace air and other gases therefrom. As will be disclosed hereinafter, the flat occlusion cuff 1 is positioned by a physician during implant surgery so as to articulate a patient's bowel and thereby selectively and variably control occluding and relaxing the bowel to promote or obturate the movement of fecal material therethrough.
Occlusion cuff 1 may include a plate containing x-ray opaque serialization indicia 4 which is typically fabricated from gold, platinum, tantalum, or the like, to provide suitable identifying information for purposes of quality assurance and manufacturing traceability. An expansible pressure sensor and indicator 5 receives the x-ray opaque fluid from the hollow chamber 2 of occlusion cuff 1 so as to be able to provide a visual indication of the fluid generated pressure therewithin. The information provided by sensor-indicator 5 may be interpreted by a nomograph (not shown) to indicate the occlusive pressures being applied to the patient's bowel.
Also communicating with the hollow chamber 2 of occlusion cuff 1 is a primary, fluid filled path 6. Primary fluid path 6 includes tubing which is preferably manufactured from a high durometer, bicompatible material, such as silicone or polyurethane. More particularly, a first section of tubing 8 extends between an inlet/outlet of occlusion cuff 1 and a tube connector 10 arranged in the primary fluid path 6. The first section of tubing 8 may be fabricated as a continuous series of extensible, shock absorbing and kink-resistant helically wound rings which provide a force damping characteristic to insulate delicate tissue and inherent length adjustment to accommodate post-operative patient movement after sphincter implantation. A second section of tubing 12 of the primary fluid path 6 extends between connector 10 and a normally closed, manually manipulatable flow control valve 14. Flow control valve 14 is of the check valve type which permits fluid flow in a single direction (in the direction of arrow 16) but opposes fluid flow in an opposite direction. Although flow control valves of this general type are well known and commercially available, one such valve which is particularly suitable for application herein is described in copending patent application Ser. No. 574,596 filed Jan. 27, 1984.
A third section of tubing 18 of primary fluid path 6 extends between flow control valve 14 and a tube connector 20. A fourth tubing section of primary fluid path 6 has a Y-shaped configuration and extends from connector 20 to each of a remote physician control port 24 (via physician access tubing 22-1) and a tube connector 26 (via tubing section 22-2). The physician control port 24 will be described in detail hereinafter when referring to FIG. 5 of the drawings. A fifth section of tubing 28 extends between connector 26 and a patient controlled, hemispheric fluid reservoir-actuator 30. The reservoir-actuator 30 will be described in greater detail hereinafter when referring to FIGS. 6 and 7 of the drawings.
Also communicating with the hollow chamber 2 of occlusion cuff 1 is a secondary fluid filled path 32. Secondary fluid path 32 includes tubing which is manufactured from the same biocompatible material used to fabricate the tubing of primary fluid path 6. More particularly, a first section of tubing 34 of secondary fluid path 32 extends between another inlet/outlet of occlusion cuff 1 and a tube connector 36. Like the first tubing section 8 of primary fluid path 6, the first tubing section 34 of secondary fluid path 32 may be formed as a continuous series of extensible, shock absorbing and kink resistant helically wound rings.
A second section of tubing 38 of second fluid path 32 extends between connector 36 and a normally closed, manually manipulatable flow control valve 40. Similar to the flow control valve 14 of primary fluid path 6, flow control valve 40 permits fluid flow in a single direction (e.g. in the direction of arrow 42) but opposes fluid flow in an opposite direction. Therefore, flow control valve 40 may be identical to flow control valve 14. A third section of tubing 44 extends between flow control valve 40 and a patient controlled hemispheric fluid reservoir-actuator 46. Like the reservoir-actuator 30 arranged in primary fluid path 6, the reservoir-actuator 46 arranged in secondary fluid path 32 will be described in greater detail when referring to FIGS. 6 and 7 of the drawings.
Details of the continence producing occlusion cuff 1 are now described while referring concurrently to FIGS. 2, 3 and 4 of the drawings. As previously indicated, and as is best shown in FIG. 4, the occlusion cuff 1 comprises a generally flat, hollow tensile resistant member. A tapered distal aspect 50 of solid cross section is coextensively formed with occlusion cuff 2 at one end thereof. A narrow locking ridge 53' extends across the occlusion cuff at the interface of the distal aspect 50 and the flat occlusion cuff member. The distal aspect 50 comprises a flexible, surgical mesh reinforced locking strap 51 having a delta-shaped locking tab 52 projecting therefrom. Extending from the end of occlusion cuff 1 opposite distal aspect 50 is a metal retaining clip 53. A locking loop 54 is positioned adjacent retaining clip 53.
During implant surgery, the physician secures the occlusion cuff 1 around the patient's bowel (as best shown in FIG. 1) by pulling the locking stray 51 of distal aspect 50 under the retaining clip 53 and through the locking loop 54 such that the locking ridge 53' is engaged and retained by clip 53 and the locking tab 52 is received by locking loop 54. The clip 53 and ridge 53' cooperate as a locking mechanism to prevent the accidental loosening or disengagement of occlusion cuff 1 from the patient's bowel. The dimensions of locking tab 52 relative to locking loop 54 are chosen to prevent the unintended release of tab 52 from loop 54. Thus, tab 52 and loop 54 cooperate as a redundant locking mechanism (with clip 53 and ridge 53') to ensure against the inadvertent loosening or removal of occlusion cuff 1 from the patient's bowel.
An important feature of continence producing occlusion cuff 1 is the inclusion of a resilient, super-expansive area 56. In the embodiment illustrated, super-expansive area 56 is located between the flat, tensile resistant member of occlusion cuff 1 and the distal aspect 50. More particularly, super-expansive area 56 comprises an extensible membrane having a spring-like memory. The membrane is provided with an array of apertures 57 extending therethrough. Although the apertures 57 illustrated in FIGS. 2-4 are circular, it is to be understood that any other suitable aperture configuration, such as rectangular windows, elongated slits, and the like, may be substituted therefor. A lateral guide clip 58 is located across occlusion cuff 1 at the interface of membrane 56 and distal aspect 50.
In FIG. 2 of the drawings, the continence producing occlusion cuff 1 is shown embracing an intestinal lumen (e.g. a bowel). The occlusion cuff 1 is in a non-distended condition, such that super-expansive membrane 56 is relaxed relative to the position of guide clip 58, whereby the adjusting clip 53 and guide clip 58 ends of cuff 1 are located adjacent one another. In FIG. 3 of the drawings, the bowel is impacted. Occlusion cuff 1 is now shown in a distended condition, such that extensible, super-expansive membrane 56 is stretched beyond guide clip 58, whereby the adjusting clip 53 and guide clip 58 ends of cuff 1 are separated from one another. Accordingly, and by virtue of the present invention, the occlusion cuff 1 is adapted to accommodate a distension of a patient's bowel corresponding to the separated distance between the adjusting clip and guide clip ends of cuff 1 when super-expansion membrane 56 is stretched therebetween. When the impacted bowel regains its normal size (of FIG. 2), the guide clip 58 ensures that the adjusting clip and guide clip ends of cuff 1 will return to their original adjacent alignment with one another.
The area of the apertures 57 formed in membrane 56 establishes the threshhold pressure level at which the expansion of membrane 56 begins. That is, the greater the total area of apertures 57, the smaller is the expansive pressure which needs to be exerted by the impacted bowel on occlusion cuff 2 before membrane 56 can be stretched past positioning clip 58. Hence, by selecting a particular number and dimension of apertures 57, the pressure-expansion characteristics of occlusion cuff 1 can be tailored to the tissue requirements of the patient.
The physician control port 24 of FIG. 1 is now described in detail while referring to FIG. 5 of the drawings. Physician control port 24 comprises an exterior body 62 formed from a relatively high durometer, bicompatible material, such as silicone, polyurethane, or the like. Located at the interior of control port 24 is a hollow, metallic housing 63 having a canted shoulder 64 extending therearound. A high durometer membrane 65 extends across the hollow interior of physician control port 24 so as to establish upper and lower control port compartments 66 and 68. During sphincter manufacture, the upper compartment 66 is filled with a self-healing polymer gel, and the lower compartment 68 is filled with a (e.g. low viscosity, isotonic radio-opaque) fluid. The fluid filled compartment 68 communicates with a section of tubing 22-1 from the primary fluid path 6 of FIG. 1. A silicone impregnated, reinforcing surgical mesh 69 is connected across the physician control port 24 and provides a surface by which to permit a physician to surgically attach (e.g. by means of sutures) the control port to the subcutaneous tissue 70 of the patient. The physician control port 24 may be implanted at any suitably accessible location, such as the inguinal area of the patient. However, it is desirable to locate control port 24 remotely from the fluid reservoir-actuators 30 and 46, so as to avoid damage thereto during the soon-to-be-described physician actuation of control port 24.
In the event that sufficient patient initiated occlusive pressure cannot be generated to achieve coaptive continence (by means of actuating the primary and secondary fluid reservoir-actuators 30 and 46 of FIG. 1), the physician may continuously and accurately increase the maximum available occlusive pressure to be applied by the continence producing occlusion cuff 1 to the patient's bowel. More particularly, the physician inserts the tip of a syringe 72 containing an additional supply of fluid through the self-healing polymer gel 66 and membrane 65 into the fluid filled compartment 68 of control port 24. The canted shoulder 64 of control port 24 acts as a self-locating stop for automatically receiving and positioning the tip of syringe 72. Fluid filled compartment 68 is then percutaneously infused with a minimum additional volume of fluid, whereby to force a supply of existing fluid from compartment 68 into tubing section 22-1 (in the direction of arrow 73) and through the primary fluid path 6 of FIG. 1. A carefully controlled amount of fluid is introduced into the primary fluid path 6 to cause an increased inflation of the fluid filled chamber 2 of occlusion cuff 1, until the minimum increased occlusive pressure necessary to achieve coaptive continence is generated. The physician then withdraws the syringe, whereupon the polymer gel within compartment 66 acts to heat the remaining puncture wound and thereby minimizes possible leakage from and damage to physician control port 24.
The identically constructed primary and secondary fluid reservoir-actuators 30 and 46 of FIG. 1 are now described while referring to FIGS. 6 and 7 of the drawings. Each reservoir-actuator 30 and 46 comprises a hemispheric outer actuator body 75 which is coextensively formed with an inner locating ring 76. It is to be understood that the hemispheric shape of actuator body 75 is not to be regarded as a limitation of this invention, and other suitable shapes may be substituted therefor. The outer body 75 and inner locating ring 76 of reservoir-actuators 30 and 46 are formed from a suitable biocompatible material, such as silicone, polyurethane, or the like. The hemispheric actuator body 75 is constructed so as to be both flexible and tear resistant. The inner locating ring 76 is constructed to enable a patient to manually locate the reservoir-actuator while in situ. The hemispheric outer actuator body 75 is disposed over and around the inner locating ring 76 so as to form a hollow reservoir 77 which is filled with a (e.g. low viscosity, isotonic, radio-opaque) fluid. Fluid filled reservoir 77 communicates with the primary and secondary fluid paths 6 and 32 of FIG. 1 by way of respective tubing sections 28 and 44. A silicone impregnated, reinforcing surgical mesh 78 is connected across each fluid reservoir-actuator 30 and 46 to provide a surface by which to permit a physician to surgically attach (e.g. by means of sutures) the reservoir-actuator to the subcutaneous tissue of the patient. By way of example, the fluid reservoir-actuators 30 and 46 are located so as to be manually accessible, such as at the anterior ileal crest of the patient.
In the event that the patient wishes to increase the occlusive pressures to be applied from the occlusion cuff to his bowel to achieve coaptive continence, he first locates one of the primary or secondary fluid reservoir-actuators 30 or 46 by means of the locating ring 76 thereof. The patient then depresses the flexible hemispheric actuator body 75 (in the direction indicated by the arrow 79 of FIG. 6), whereby to compress the fluid filled reservoir 77 (best shown in FIG. 7) and thereby force a supply of fluid from reservoir 77 into tubing section 28 or 44 (in the direction indicated by arrow 80 of FIG. 7) and through the primary or secondary fluid path 6 or 32. Accordingly, fluid is transmitted to the occlusion cuff in order to cause the chamber thereof to inflate. However, the patient may have to actuate both actuator-reservoirs 30 and 46 (in the manner just described) to cause a sufficient inflation of the occlusion cuff chamber and a corresponding occlusive pressure necessary to achieve coaptive continence.
By virtue of the presently disclosed sphincter and the single, continuous fluidic circuit thereof (best illustrated in FIG. 1), variable occlusive pressure levels can be selectively established for applying diametric compression to a bowel for holding a patient continent. That is, when the patient controlled, primary fluid reservoir-actuator 30 is actuated, the primary fluid path 6 transmits sufficient fluid therethrough by which to partially inflate the hollow chamber 2 of continence producing occlusion cuff 1 and thereby achieve a first (i.e. fecal continence) occlusive pressure level. At such fecal continence pressure level, methane gas may pass through the patient's colon. However, the passage of fecal material throught the colon is otherwise impeded. When the patient controlled, secondary fluid reservoir-actuator 46 is also manually actuated, the secondary fluid path transmits additional fluid therethrough by which to further inflate the chamber 2 of occlusion cuff 1 so as to achieve a second (i.e. flatus continence) occlusive pressure level. At such flatus continence pressure level, neither methane gas nor fecal material may pass through the colon. The presence of physician control port 24 permits limited additional fluid to be transmitted to occlusion cuff 1 via primary fluid path 6 to further increase the inflation of chamber 2 and thereby achieve a maximum occlusive pressure level, according to the tissue requirements of the patient.
Occassionally, however, the patient wishes to discharge both gaseous and fecal matter through his bowel. Therefore, it periodically becomes necessary to reduce the occlusive pressures being applied to the patient's bowel by the fluid filled chamber 2 of occlusion cuff 1. Accordingly, one or both of the primary or secondary flow control valves 14 or 40 are manually manipulated and thereby opened (in a manner described in the aforementioned patent application Ser. No. 574,596 filed Jan. 27, 1984), whereby to shrink the chamber 2 of occlusion cuff 1 and permit fluid to return to the primary and/or secondary reservoir-actuators via the respective fluid paths 6 and 32 (in a direction represented by the arrow 82 of FIG. 6). The opening of both flow control valves 14 and 40 causes the fluid filled occlusion cuff 2 to shrink to its original and unexpanded size, the reservoir-actuators 30 and 46 to inflate to their original, expanded size, and the occlusive pressures being applied to the patient's bowel to be minimized. Of course, only one of the primary or secondary flow control valves 14 or 40 need be opened to cause a partial shrinking of the fluid filled chamber and a reduction in the occusive pressures being applied thereby. An occassional reduction in the occlusive pressure is also desirable to maximize circulatory blood flow through the bowel and reduce the possibility of ischemia, erosion and/or necrosis.
It is to be recognized that the aforementioned variable occlusive pressure levels are achieved by means of a single, multi-access occlusion cuff chamber 2 which communicates with each of the primary and secondary fluid paths 6 and 32. It is also to be recognized that unlike conventional sphincters, the presently disclosed sphincter may be regarded as a dual purpose, multi-threshhold device. That is, while the continuous fluidic circuit of FIG. 1 is adapted to establish variable occlusive pressure levels to articulate a bowel and hold a patient continent, the super-expansive membrane 56 of FIGS. 2 and 3 provides the occlusion cuff 1 with the ability to accommodate a distended colon, such as that caused by fecal impaction. The threshhold pressure level at which the expansion of membrane 56 begins can be selectively controlled, depending upon the dimension of the apertures 57 formed therein.
An automatic, self-centering feature of the present invention is briefly explained while concurrently referring to FIGS. 8, 9 and 10 of the drawings. In FIG. 8, an uninflated occlusion cuff 1 is closed around a lumen 84 (e.g. bowel) of a patient. As fluid is conveyed to the continence producing occlusion cuff 1, the thin wall sections of the hollow chamber thereof begin to expand first (FIG. 9), whereby to automatically relocate the bowel towards the center of the cuff and thereby avoid a possible pinching of the bowel. With the chamber of occlusion cuff 1 fully inflated (FIG. 10), the bowel will be centrally and optimally disposed, so as to receive diametric occlusive pressure by which to reliably and efficiently achieve coaptive continence.
It will be apparent that while a preferred embodiment of the invention has been shown and described, various modifications and changes may be made without departing from the true spirit and scope of the invention. By way of example, although the fluid paths 6 and 32 have been designated primary and secondary, respectively, this is not to be regarded as a limitation of the invention. It is therefore to be understood that either fluid path 6 or 32 may be regarded as primary or secondary. Likewise, and since each of the fluid paths 6 and 32 communicate with the hollow chamber 2 of occlusion cuff 1 via a single, continuous fluidic circuit, the fluid reservoir-actuators 30 and 46 may be actuated in any order to establish the variable occlusive pressure levels, whereby to achieve coactive continence. What is more, the physician control port 24 may communicate with occlusion cuff 2 via either the primary or secondary fluid path 6 or 32.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US1810027 *||8 May 1930||16 Jun 1931||Robert Malcom||Strap|
|US2271927 *||16 Jun 1938||3 Feb 1942||Edward S Saighman||Tourniquet|
|US4019499 *||22 Apr 1976||26 Apr 1977||Heyer-Schulte Corporation||Compression implant for urinary incontinence|
|US4222377 *||27 Jun 1977||16 Sep 1980||American Medical Systems, Inc.||Pressure regulated artificial sphincter systems|
|US4419985 *||24 Mar 1982||13 Dec 1983||Medical Engineering Corporation||Apparatus for reversibly closing a body passage|
|US4549531 *||3 Aug 1984||29 Oct 1985||Medical Engineering Corporation||Artificial sphincter with inflatable cuff|
|US4551862 *||15 Dec 1982||12 Nov 1985||Haber Terry M||Prosthetic sphincter|
|US4571749 *||21 Sep 1982||25 Feb 1986||The Johns Hopkins University||Manually actuated hydraulic sphincter|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4781695 *||11 Jul 1986||1 Nov 1988||Dalton Michael J||Implantable fluid dispenser|
|US4786276 *||1 Jul 1987||22 Nov 1988||Habley Medical Technology Corporation||Triple cushion sphincteric web|
|US4846784 *||1 Jul 1987||11 Jul 1989||C. R. Bard, Inc.||Manually adjustable sphincteric system|
|US4886501 *||6 Feb 1989||12 Dec 1989||Shiley Infusaid Inc.||Implantable device|
|US4902294 *||30 Nov 1987||20 Feb 1990||Olivier Gosserez||Implantable mammary prosthesis adapted to combat the formation of a retractile shell|
|US4961725 *||21 Aug 1987||9 Oct 1990||Centre National De La Recherche Scientifique||Device for controlling the flow of a fluid and a prosthetic organ equipped with this device|
|US5147389 *||8 Nov 1991||15 Sep 1992||Vaso Products Australia Pty Limited||Correction of incompetent venous valves|
|US5181922 *||29 Jul 1991||26 Jan 1993||Escalon Ophthalmics, Inc.||Method for indenting the ocular coats of an eye|
|US5366474 *||13 Aug 1992||22 Nov 1994||Escalon Ophthalmics, Inc.||Apparatus and method for indenting the ocular coats of an eye|
|US5562598 *||20 Sep 1994||8 Oct 1996||Whalen Biomedical Inc.||Artificial urethral sphincter|
|US5792042 *||8 Aug 1996||11 Aug 1998||Cohen; Kenneth L.||Apparatus for treating incontinence in females|
|US5795288 *||8 Aug 1996||18 Aug 1998||Cohen; Kenneth L.||Apparatus with valve for treating incontinence|
|US5911757 *||7 Jun 1995||15 Jun 1999||Seare, Jr.; William J.||Methods and apparatus for transcutaneous access|
|US6491623 *||25 Jan 2001||10 Dec 2002||Harridan Medical||Device for preventing fecal incontinence|
|US6592623 *||31 Aug 1999||15 Jul 2003||Virginia Commonwealth University Intellectual Property Foundation||Engineered muscle|
|US7601162 *||14 Jan 2005||13 Oct 2009||Ethicon Endo-Surgery, Inc.||Actuator for an implantable band|
|US7771346||13 Jan 2006||10 Aug 2010||Uromedica, Inc.||Apparatus and method for inserting an adjustable implantable genitourinary device|
|US7828716||19 Mar 2008||9 Nov 2010||Uromedica, Inc.||Implantable device and method for adjustably restricting a body lumen|
|US7879068||8 Mar 2007||1 Feb 2011||Ethicon Endo-Surgery, Inc.||Feedback sensing for a mechanical restrictive device|
|US7918782||17 Nov 2008||5 Apr 2011||Ams Research Corporation||Prosthesis with bladder that adjusts girth|
|US7988616||1 Oct 2003||2 Aug 2011||Potencia Medical Ag||Implantable pump for operation of hydraulic implant|
|US8029434||4 May 2006||4 Oct 2011||Aesculap Ag||Device for the prevention of incontinence, especially urinary incontinence|
|US8152710||28 Feb 2008||10 Apr 2012||Ethicon Endo-Surgery, Inc.||Physiological parameter analysis for an implantable restriction device and a data logger|
|US8317676 *||14 May 2007||27 Nov 2012||Ethicon Endo-Surgery, Inc.||Gastric band with contrasting supply tube|
|US8357080 *||14 May 2007||22 Jan 2013||Ethicon Endo-Surgery, Inc.||Tissue contrasting gastric band|
|US8425401 *||30 Jan 2009||23 Apr 2013||Medical Components, Inc.||Gastric inflation band with integrated infusion catheter|
|US8485964 *||15 May 2007||16 Jul 2013||Ethicon Endo-Surgery, Inc.||Gastric band with supply tube check valve|
|US8545384||1 Feb 2010||1 Oct 2013||Obtech Medical Ag||Anal incontinence disease treatment with controlled wireless energy supply|
|US8545391||22 Dec 2009||1 Oct 2013||Ams Research Corporation||Penile prosthesis implantation device|
|US8556796||15 Jan 2010||15 Oct 2013||Obtech Medical Ag||Controlled urinary incontinence treatment|
|US8600510||9 Oct 2009||3 Dec 2013||Milux Holding Sa||Apparatus, system and operation method for the treatment of female sexual dysfunction|
|US8602966||25 Apr 2008||10 Dec 2013||Obtech Medical, AG||Mechanical impotence treatment apparatus|
|US8657735 *||14 Jan 2005||25 Feb 2014||Medical Innovation Developpement||Gastric belt|
|US8696543||14 Oct 2008||15 Apr 2014||Kirk Promotion Ltd.||Method for controlling flow of intestinal contents in a patient's intestines|
|US8734318||28 Jun 2006||27 May 2014||Obtech Medical Ag||Mechanical anal incontinence|
|US8764627||10 Sep 2008||1 Jul 2014||Obtech Medical Ag||Penile prosthesis|
|US8795153||14 Oct 2008||5 Aug 2014||Peter Forsell||Method for treating female sexual dysfunction|
|US8821371||29 Jul 2011||2 Sep 2014||Potencia Medical Ag||Implantable pump for operation of hydraulic implant|
|US8864651||26 Sep 2013||21 Oct 2014||Ams Research Corporation||Penile prosthesis implantation device|
|US8870742||28 Feb 2008||28 Oct 2014||Ethicon Endo-Surgery, Inc.||GUI for an implantable restriction device and a data logger|
|US8874215||9 Oct 2009||28 Oct 2014||Peter Forsell||System, an apparatus, and a method for treating a sexual dysfunctional female patient|
|US8992409||12 Apr 2010||31 Mar 2015||Peter Forsell||Method for controlling flow in a bodily organ|
|US9005111||22 Jul 2014||14 Apr 2015||Ams Research Corporation||Penile prosthesis implantation device|
|US9089426||14 Mar 2013||28 Jul 2015||Ams Research Corporation||Automated implantable penile prosthesis pump system|
|US9095406 *||7 Aug 2012||4 Aug 2015||Boston Scientific Scimed, Inc.||Shape memory controller|
|US20060025798 *||22 Feb 2005||2 Feb 2006||Cook Timothy C||Method and apparatus for fecal continence|
|US20060127246 *||1 Oct 2003||15 Jun 2006||Potenica Medical Ag||Implantable pump for operation of hydraulic implant|
|US20060161186 *||14 Jan 2005||20 Jul 2006||Ethicon Endo-Surgery, Inc.||Actuator for an implantable band|
|US20060241339 *||23 Feb 2006||26 Oct 2006||Cook Timothy C||Method and apparatus for an adjustable implantable continence device|
|US20060281964 *||13 Jan 2006||14 Dec 2006||Uromedica, Inc.||Apparatus and method for inserting an adjustable implantable genitourinary device|
|US20070073099 *||28 Jun 2006||29 Mar 2007||Obtech Medical Ag||Mechanical anal incontinence|
|US20110196194 *||9 Oct 2009||11 Aug 2011||Milux Holding Sa||Implantable device for internal urinary control|
|US20130041207 *||7 Aug 2012||14 Feb 2013||Boston Scientific Scimed, Inc.||Shape memory controller|
|US20130053626 *||28 Feb 2013||Ams Research Corporation||Fecal Incontinence Treatment Device and Method|
|US20130144269 *||2 Dec 2011||6 Jun 2013||Cook Medical Technologies Llc||Drainage system with occlusion member|
|US20150025303 *||19 Jul 2013||22 Jan 2015||Coloplast A/S||One-piece monolithic cuff and artificial urinary sphincter system|
|CN101305941B||15 May 2008||4 Jan 2012||伊西康内外科公司||Gastric band with supply tube check valve|
|CN101305942B||13 May 2008||9 Jan 2013||伊西康内外科公司||Tissue contrasting gastric band|
|EP2856983A1||14 Jul 2010||8 Apr 2015||Stimatix Gi Ltd.||Stomal cover|
|WO1989000030A1 *||1 Jul 1988||12 Jan 1989||Bard Inc C R||Manually adjustable sphincteric system|
|WO1993002624A1 *||23 Jul 1992||18 Feb 1993||Escalon Ophthalmics Inc||Apparatus and method for indenting the ocular coats of an eye|
|WO2001054615A2||25 Jan 2001||2 Aug 2001||Harridan Medical||Device for preventing fecal incontinence|
|WO2006117214A1||4 May 2006||9 Nov 2006||Aesculap Ag & Co Kg||Device for the prevention of incontinence, especially urinary incontinence|
|WO2011007355A2||14 Jul 2010||20 Jan 2011||Stimatix Gi Ltd.||Ostomy containment device|
|U.S. Classification||600/31, 128/DIG.25, 623/14.13|
|International Classification||A61F2/04, A61F2/08, A61F2/00|
|Cooperative Classification||Y10S128/25, A61F2/004|
|3 Feb 1986||AS||Assignment|
Owner name: HABLEY MEDICAL TECHNOLOGY CORPORATION, 23181 VERDU
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:HABER, TERRY M.;REEL/FRAME:004511/0316
Effective date: 19860128
|14 Aug 1990||REMI||Maintenance fee reminder mailed|
|6 Jan 1991||FPAY||Fee payment|
Year of fee payment: 4
|6 Jan 1991||SULP||Surcharge for late payment|
|21 Jun 1994||FPAY||Fee payment|
Year of fee payment: 8
|28 Jul 1998||REMI||Maintenance fee reminder mailed|
|3 Jan 1999||LAPS||Lapse for failure to pay maintenance fees|
|16 Mar 1999||FP||Expired due to failure to pay maintenance fee|
Effective date: 19990106